GE Healthcare Inc

GE Healthcare Technologies insider purchase signals confidence; strong AI‑driven imaging, R&D growth, supply‑chain resilience, and FDA pre‑cert boost future prospects.

Insider buys at GE HealthCare reveal executive confidence, yet analysts trim targets and a fiduciary‑duty probe looms—read the full impact on stock and strategy.

GE Healthcare Q1 earnings miss hits stock; revenue up 3.8% while margins shrink. Analysts weigh inflation, supply‑chain, and AI‑driven growth prospects.

GE Healthcare expands its $35 M BARDA partnership to develop AI‑enabled ultrasound, speeding trauma diagnostics, cutting costs and easing operator demands.

GE Healthcare’s latest earnings beat, analyst lift, and institutional moves reveal a cautious outlook amid regulatory and AI‑driven competition, highlighting risks and growth prospects.

GE Healthcare’s $105 M Indonesian CT scanner deal and renewed Vaso partnership illustrate a strategic push into Southeast Asia’s growing diagnostic imaging market, backed by debt, equity and AI‑enabled tech to drive ROI and NCD screening.

GE HealthCare unveils its next‑generation SIGNA™ MRI platform at RSNA 2025, showcasing advanced image quality, AI‑powered workflows, and regulatory progress for precision‑care imaging.

GE Healthcare has announced a dual-strategy approach, partnering with CardioNavix to bring advanced cardiac imaging agent Flyrcado to the US and launching the Revolution Vibe CT Imaging System, which promises to raise the bar for image quality and w…

GE HealthCare has unveiled its Vivid Pioneer, an AI-powered cardiovascular ultrasound system that is poised to revolutionize the field of cardiology with unparalleled diagnostic capabilities and enhanced patient outcomes.

GE Healthcare has unveiled Vivid Pioneer, an AI-powered cardiovascular ultrasound system that offers improved image quality, accuracy, and efficiency, revolutionizing the field of cardiovascular diagnostics.